Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × galactomannan × Clear all

NCT00388700 2018-02-14

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00110721 2012-03-06

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms